LC
GDRX icon

Lindbrook Capital’s GoodRx Holdings GDRX Stock Holding History

Lindbrook Capital’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-95
Closed -$659 – 2828
2024
Q3 		$659 Sell
95
-65
-41% -$510 ﹤0.01% 2596
2024
Q2 		$1.25K Buy
160
+65
+68% +$481 ﹤0.01% 2454
2024
Q1 		$675 Buy
95
+35
+58% +$232 ﹤0.01% 2485
2023
Q4 		$402 Sell
60
-89
-60% -$501 ﹤0.01% 2597
2023
Q3 		$839 Sell
149
-1,025
-87% -$6.83K ﹤0.01% 2404
2023
Q2 		$6.48K Buy
1,174
+200
+21% +$1.08K ﹤0.01% 1685
2023
Q1 		$6.09K Buy
974
+914
+1,523% +$5.09K ﹤0.01% 1767
2022
Q4 		$280 Buy
+60
New +$296 ﹤0.01% 2688
2021
Q1 		– Sell
-2,500
Closed -$101K – 1897
2020
Q4 		$101K Buy
+2,500
New +$115K 0.02% 243

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lindbrook Capital's GDRX Position: Q4 2024 in Review

Lindbrook Capital sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 95 shares — an estimated $659 sold.

Lindbrook Capital first reported a position in GDRX in Q4 2020 and held it in 9 quarters. The position peaked at $101K in Q4 2020. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Lindbrook Capital reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Lindbrook Capital sold 95 GoodRx Holdings shares in Q4 2024, an estimated $659.
  • Lindbrook Capital first reported a position in GoodRx Holdings in Q4 2020 and held it in 9 quarters.
  • Lindbrook Capital's GoodRx Holdings position peaked at $101K in Q4 2020.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.